FDA Follow-On Biologics Guidance Due In Spring; Woodcock Leads Effort

FDA is planning to release a draft guidance on follow-on biologics in the spring

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet